Analytic Investors’s Amdocs DOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$119M Sell
2,057,784
-32,854
-2% -$1.94M 1.33% 18
2016
Q2
$121M Buy
2,090,638
+63,423
+3% +$3.64M 1.43% 16
2016
Q1
$122M Buy
2,027,215
+811,821
+67% +$45.5M 1.49% 13
2015
Q4
$66.3M Sell
1,215,394
-138,122
-10% -$7.92M 0.83% 35
2015
Q3
$77M Sell
1,353,516
-135,889
-9% -$7.78M 1.03% 27
2015
Q2
$81.3M Sell
1,489,405
-38,760
-3% -$2.13M 1.14% 25
2015
Q1
$83.1M Sell
1,528,165
-4,725
-0.3% -$238K 1.14% 26
2014
Q4
$71.5M Buy
+1,532,890
New +$71.8M 1.02% 26
2014
Q3
Sell
-1,533,991
Closed -$71.1M 613
2014
Q2
$71.1M Buy
+1,533,991
New +$72.2M 1.15% 24
2013
Q4
Sell
-1,074,751
Closed -$39.4M 520
2013
Q3
$39.4M Buy
1,074,751
+549,928
+105% +$20.8M 0.63% 42
2013
Q2
$19.5M Buy
+524,823
New +$18.7M 0.32% 105

Other funds holding DOX

Analytic Investors's DOX Position: Q3 2016 in Review

Analytic Investors reduced its Amdocs (DOX) stake by 1.6% in Q3 2016, selling an estimated $1.94M and leaving 2,057,784 shares worth $119M. The position accounts for 1.33% of the portfolio, ranked #18.

Analytic Investors first reported a position in DOX in Q2 2013 and has held it in 11 quarters since. The position peaked at $122M in Q1 2016. 357 funds tracked by Wall St. Rank hold DOX as of Q3 2016.

  • Analytic Investors held 2,057,784 shares of Amdocs worth $119M as of Q3 2016.
  • Analytic Investors sold 32,854 Amdocs shares in Q3 2016, an estimated $1.94M.
  • Amdocs made up 1.33% of Analytic Investors's portfolio in Q3 2016, its #18 holding.
  • Analytic Investors first reported a position in Amdocs in Q2 2013 and has held it in 11 quarters since.
  • Analytic Investors's Amdocs position peaked at $122M in Q1 2016.
  • 357 funds tracked by Wall St. Rank held Amdocs as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.